Member Companies Donation
Since the outbreak of COVID-19, many RDPAC member companies have taken rapid assistance actions. Up to now, more than 35 RDPAC member companies have successively donated cash and medical supplies with a total value of more than RMB 190 million details >
Patient Access to Medications
- Adhering to the “patient-centric” concept, RDPAC member companies timely returned to work and production to ensure medicine supply. They also provide patients with disease management, medication guidance, drug purchase and delivery services through Internet and other channels, so as to escort the life of patients with chronic diseases.
- RDPAC Hubei business working group launched the “Public Service of Special Care and Seeking Drugs for Hubei”. Through active cooperation with relevant parties, they solve the problem of difficult to buy medicine for patients and the general public during the epidemic period.
Industry Internet Code of Conduct
In the special period of epidemic, "Internet +" medical service plays an advantage role for member companies to better serve patients. To this end, RDPAC member companies timely stressed the importance of the ethical code of business conduct that the industry should abide by under the new “Internet +” format, as well as the concept of implementing the industry code, so as to provide timely support for the industry and member companies to continuously maintain and improve the level of compliance operation.
Drug and vaccine R&D against COVID-19
RDPAC member companies are accelerating drugs and vaccines R&D against COVID-19, actively promoting clinical trials and related registrations, and sharing research and development platforms. At the same time, urgent screening of existing drug and vaccine databases, actively looking for ways to fight COVID-19.
Industry Policy Suggestion and Communication
Through empirical research, RDPAC actively makes suggestions to relevant government departments, promotes the development of “Internet +” online medical services during the epidemic period, and encourages online drug purchase to be included in medical insurance payment, so as to contribute wisdom to the designation and improvement of China's pharmaceutical policy and build China's pharmaceutical innovation ecosystem
Bridge and connection
RDPAC is committed to leveraging its resources, delivering industry voices, actively communicating and coordinating with the government, industry associations and authorities at home and abroad, seeking solutions for the supply of scarce materials, and promoting clinical trials of drugs and vaccines.
